Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
154.9 USD | +1.04% | +3.87% | +16.21% |
Apr. 25 | BNP Paribas Exane Raises Fiserv's Price Target to $172 From $170, Outperform Rating Maintained | MT |
Apr. 25 | Wedbush Raises Fiserv's Price Target to $170 From $160 | MT |
Evolution of the average Target Price on Fiserv, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Fiserv, Inc.
BNP Paribas Exane | |
Wedbush | |
UBS | |
Wolfe Research | |
B. Riley | |
Goldman Sachs | |
Northcoast Research | |
TD Cowen | |
RBC Capital Markets | |
Evercore ISI | |
Morgan Stanley | |
Bernstein | |
Raymond James | |
BMO Capital | |
Citigroup | |
Baird | |
KeyBanc Capital Markets | |
Autonomous Research | |
JPMorgan Chase | |
Barclays | |
Jefferies & Co. | |
Susquehanna | |
Mizuho Securities | |
Oppenheimer | |
Tigress Financial | |
Seaport Global Securities | |
Morningstar | |
Monness, Crespi, Hardt | |
Credit Suisse | |
Stephens Inc. | |
Truist Securities | |
Wells Fargo Securities | |
Atlantic Equities | |
Loop Capital | |
Berenberg Bank | |
Rosenblatt Securities | |
Cowen | |
BofA Securities | |
Edward Jones | |
Exane BNP Paribas |
EPS Revisions
- Stock Market
- Equities
- FI Stock
- Consensus Fiserv, Inc.